[Legionnaires' disease. Immunity and immunosuppression].
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use*; D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D000942:Antigens, Bacterial / Q000276:immunology; D002283:Carcinoma, Bronchogenic / Q000150:complications / Q000188:drug therapy; D003165:Complement System Proteins / Q000276:immunology; D006168:Guinea Pigs; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007875:Legionella / Q000145:classification / Q000276:immunology; D007877:Legionnaires' Disease / Q000097:blood / Q000209:etiology / Q000276:immunology*; D007938:Leukemia / Q000150:complications / Q000188:drug therapy; D008264:Macrophages / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy; D009504:Neutrophils / Q000276:immunology; D010587:Phagocytosis; D011379:Prognosis
D000305:Adrenal Cortex Hormones; D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D003165:Complement System Proteins
Maladie des légionnaires. Immunité et immunodépression.